Testicular cancer: determinants of cisplatin sensitivity and novel therapeutic opportunities

Testicular cancer (TC) accounts for approximately 1% of all cancers in men worldwide, while it is the most common solid tumor among young men (15-40 years) [1]. Incidence of TC varies widely across different regions, with highest incidence in Northern Europe and very low incidence in central Africa [1]. Incidence rates of TC have increased since the 1960s in Northern European countries, affecting age groups older than 15 years with no proven causative mechanisms identified so far [2].

Source: Cancer Treatment Reviews - June 7, 2020 Category: Cancer & Oncology Authors: Gerda de Vries, Ximena Rosas-Plaza, Marcel A.T.M. van Vugt, Jourik A. Gietema, Steven de Jong Tags: Tumour Review Source Type: research